Friday, July 10, 2026

pharma · Mantle Cell Lymphoma · Colon cancer

Telethon Foundation

Telethon Foundation clinical programs — 14 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

roma, IT HQ
1990 Founded
343 Employees
EMA registrant Type
Company details
Status
Public
HQ
roma, IT
Founded
1990
Employees
343
Programs
162
Drugs
285
Patents
0
Intelligence · Clinical Programs

Telethon Foundation projects

14 ClinicalTrials.gov programs sponsored by Telethon Foundation.

Telethon Foundation has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ARMYDA-AMULET

    Fondazione Telethon ETS

    Patients with atrial fibrillation undergoing percutaneous left atrial appendage closure with the Amulet device

    approved small molecule active

    1 trial
  2. BioPhenoT2D

    Fondazione Telethon ETS

    type 2 diabetes

    approved small molecule active

    1 trial
  3. CML1415 - Sustrenim

    Fondazione Telethon ETS

    Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)

    approved small molecule active

    1 trial
  4. DON3

    Fondazione Telethon ETS

    obese elderly people with vitamin D deficiency

    approved small molecule active

    1 trial
  5. ESOMEPRAZOLE, ESOMEPRAZOLE

    Fondazione Telethon ETS

    obesity

    approved small molecule active

    1 trial
  6. Enbrel powder and solvent for Juvenile Idiopathic Arthritis

    Fondazione Telethon ETS

    Juvenile Idiopathic Arthritis

    approved small molecule active

    1 trial
  7. ITALIC-RCC

    Fondazione Telethon ETS

    metastatic or locally advanced renal cell carcinoma

    approved small molecule active

    1 trial
  8. OM 85OLDER

    Fondazione Telethon ETS

    Elderly patients with a positive history of at least two respiratory system infections in the year preceding enrollment and residents for at least 6 months in a Healthcare Residence.

    approved small molecule active

    1 trial
  9. PICCOLETO IV-EPIC 38

    Fondazione Telethon ETS

    Patients with Stable or Unstable coronary syndromes who have undergone successful PCI

    approved small molecule active

    1 trial
  10. PROMISE

    Fondazione Telethon ETS

    Myocardial infarction with non-obstructive coronary arteries (MINOCA)

    approved small molecule active

    1 trial
  11. RADAR-1 CRPC

    Fondazione Telethon ETS

    metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown

    approved small molecule active

    1 trial
  12. SELECTIO-UC

    Fondazione Telethon ETS

    metastatic or locally advanced urothelial cancer

    approved small molecule active

    1 trial
  13. STAR 2

    Fondazione Telethon ETS

    electrical storm

    approved small molecule active

    1 trial
  14. TAGRISSO 80 mg film-coated tablets

    Fondazione Telethon ETS

    Patients with EGFR mutant NSCLC according to TP53 mutational status

    approved small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Telethon Foundation have?

14 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.